HDT Bio Revenue and Competitors
Estimated Revenue & Valuation
- HDT Bio's estimated annual revenue is currently $11.8M per year.
- HDT Bio's estimated revenue per employee is $155,000
- HDT Bio's total funding is $14M.
Employee Data
- HDT Bio has 76 Employees.
- HDT Bio grew their employee count by 27% last year.
HDT Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder & CEO | Reveal Email/Phone |
2 | Co-Founder & Senior Advisor | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | Director Clinical Operations | Reveal Email/Phone |
5 | Director, Regulatory Affairs | Reveal Email/Phone |
6 | Sr. Director, Finance & Accounting | Reveal Email/Phone |
7 | Director, Grants Management | Reveal Email/Phone |
8 | Senior Director | Reveal Email/Phone |
9 | Director Virology | Reveal Email/Phone |
10 | Director Formulations | Reveal Email/Phone |
HDT Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $3.3M | 43 | 10% | $101M | N/A |
#4 | $5.7M | 37 | 12% | N/A | N/A |
#5 | $7M | 45 | 41% | N/A | N/A |
#6 | $1.7M | 22 | -8% | N/A | N/A |
#7 | $3.9M | 50 | 4% | $10.1M | N/A |
#8 | $1.9M | 12 | -73% | N/A | N/A |
#9 | $29.3M | 151 | -17% | $148M | N/A |
#10 | $2M | 13 | 86% | N/A | N/A |
What Is HDT Bio?
HDT Bio Corp. is a biopharmaceutical company developing drugs for immunotherapy of cancers and infectious diseases. Our products are designed to be cost-effective solutions to unmet medical needs and complementary to existing, cutting-edge immunotherapies.
keywords:N/A
$14M
Total Funding
76
Number of Employees
$11.8M
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HDT Bio News
HDT Bio's COVID-19 vaccine is significantly different from current mRNA vaccines. Using self-replicating RNA, which is designed to amplify...
HDT Bio's innovative vaccine uses a proprietary lipid nanoparticle carrier system for delivery of RNA. The vaccine is significantly different...
HDT says that its vaccine candidate 'dramatically' improves upon the existing mRNA vaccines in two ways first it uses a special form of mRNA...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.7M | 76 | 10% | N/A |
#2 | $10.6M | 76 | -12% | $16.9M |
#3 | $19.3M | 76 | -6% | N/A |
#4 | $13.7M | 76 | 10% | N/A |
#5 | $11M | 76 | 3% | N/A |